Atrial Fibrillation DE-MRI Ablation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Paroxysmal atrial fibrillation for which ≥ 1 electrical and/or chemical cardioversions and persistent atrial fibrillation, eligible for PVI according to current international guidelines. • Age < 70 years. • Willing and able to sign informed consent. • Willing to and capable of following the requested study procedures.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Age < 18 years. • Pregnancy • Life or follow-up expectancy < 12 months. • Previous PVI in history. • Contrast allergy. • Creatin clearance level lower than 60. • MRI scanning not possible (e.g. because of metal implant or claustrophobia). • Unsuccessful PVI during first procedure, while already in study. This will lead to exclusion after randomisation. • Abnormal left atrium anatomy defined as number of PV’s ≠ 4 . This will lead to exclusion after inclusion but before randomisation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To perform a pre-study to assess the feasibility of DE-MRI to assess lesion size, transmurality and completeness of PVI. The study will be performed to determine if and how DE-MRI can be used in a subsequent multicentre study (MERCI-AF study). | — |
Secondary
| Measure | Time frame |
|---|---|
| To collect data on the use of ECI-feedback which could be included in the MERCI-AF study. | — |
Contacts
Department of Cardiology Medisch Spectrum Twente Haaksbergerstraat 55